FIELD: chemistry.
SUBSTANCE: invention relates to novel forms A and B of crystalline adefovir dipivoxil, which have improved properties during use thereof, particularly high rate of dissolution and high stability.
EFFECT: invention also relates to methods of producing forms A and B of crystalline adefovir dipivoxil.
7 cl, 10 dwg, 4 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SELECTIVE CRYSTALLISATION OF Z-ISOMER OF IOPROMIDE | 2009 |
|
RU2481325C2 |
| IMPROVED METHOD OF PRODUCING MEROPENEM USING ZINC POWDER | 2010 |
|
RU2490270C2 |
| NOVEL CRYSTALLINE FORM OF TRICYCLIC BENZOPYRAN COMPOUND AND METHOD OF ITS PRODUCTION | 2010 |
|
RU2523279C2 |
| CRYSTAL FORM OF PARP-1 INHIBITOR AND ITS PRODUCTION METHOD | 2018 |
|
RU2792620C2 |
| HIGH-PURITY CYCLOPEPTIDE CRYSTAL AS WELL AS PREPARATION METHOD AND USE THEREOF | 2013 |
|
RU2607083C2 |
| NEW CRYSTAL SOLID COMPOUND OF 3-PHENYL-4-PROPYL-1-(PYRIDINE-2-YL)-1H-PYRAZOL-5-OL HYDROCHLORIDE | 2018 |
|
RU2754255C2 |
| NEW POLYMORPHIC FORM OF A CALCIEMETRIC COMPOUND | 2011 |
|
RU2599788C2 |
| CRYSTALLINE INDOLESULFONAMIDE COMPOUND AND METHOD OF ITS OBTAINING | 2004 |
|
RU2336269C2 |
| HIGHLY STABLE COMPOSITIONS OF ORALLY ACTIVE NUCLEOTIDE ANALOGUES OR ORALLY ACTIVE NUCLEOTIDE ANALOGUE PRODRUGS | 2011 |
|
RU2606845C2 |
| CRYSTALLINE OR AMORPHOUS FORM OF FXR AGONISTS BEING STEROID DERIVATIVES, THEIR PRODUCTION METHOD AND THEIR USE | 2018 |
|
RU2800751C2 |
